VHL and renal cell carcinoma: However, when restricting analysis to the 187 RCC patients in this cohort with clinical outcomes, there was no significant association between VHL mutation and clinical outcome (P = 0.258, 73 VHL-mutated and 114 VHL-non-mutated patients).